Literature DB >> 3494669

Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor.

J M Wang, S Colella, P Allavena, A Mantovani.   

Abstract

Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) seeded in the lower compartment of chemotaxis chambers induced migration of human peripheral blood monocytes and polymorphonuclear phagocytes. rhGM-CSF was active in inducing phagocyte migration at concentrations as low as 10 CML units/ml (corresponding to 0.002 microgram), and maximal activity was observed at 10(2)-10(4)/ml. Checkerboard analysis performed by seeding different concentrations of rhGM-CSF above and below the filter revealed that maximal induction of migration required a positive concentration gradient between the lower and upper compartment, and that rhGM-CSF elicited an actual chemotactic response in phagocytes. Human umbilical vein endothelial cells and blood large granular lymphocytes (LGL) responded poorly or not at all (endothelial cells) to rhGM-CSF under conditions in which appropriate reference chemoattractants were active. The chemotactic activity of rhGM-CSF may serve to recruit phagocytic cells from the blood compartment to amplify resistance against noxious agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494669      PMCID: PMC1453246     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.

Authors:  K H Grabstein; D L Urdal; R J Tushinski; D Y Mochizuki; V L Price; M A Cantrell; S Gillis; P J Conlon
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

2.  Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E.

Authors:  J I Kurland; R S Bockman; H E Broxmeyer; M A Moore
Journal:  Science       Date:  1978-02-03       Impact factor: 47.728

3.  Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.

Authors:  M A Vadas; N A Nicola; D Metcalf
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

4.  Stimulation of macrophage plasminogen activator activity by colony-stimulating factors.

Authors:  J A Hamilton; E R Stanley; A W Burgess; R K Shadduck
Journal:  J Cell Physiol       Date:  1980-06       Impact factor: 6.384

5.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.

Authors:  W Falk; R H Goodwin; E J Leonard
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Neutrophil migration-inhibition activity produced by a unique T lymphoblast cell line.

Authors:  R H Weisbart; R Billing; D W Golde
Journal:  J Lab Clin Med       Date:  1979-04

7.  A monokine regulates colony-stimulating activity production by vascular endothelial cells.

Authors:  G C Bagby; E McCall; K A Bergstrom; D Burger
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

8.  Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses.

Authors:  G Cianciolo; J Hunter; J Silva; J S Haskill; R Snyderman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  33 in total

1.  The mechanism of mononuclear cell infiltration in oral lichen planus: the role of cytokines released from keratinocytes.

Authors:  T Yamamoto; T Nakane; T Osaki
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

Review 2.  Mechanism of GM-CSF stimulation of neutrophils.

Authors:  R G Coffey
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 3.  Colony-stimulating factors in the pathogenesis and treatment of disease.

Authors:  D J Williamson; C G Begley
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

4.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

5.  T cell-dependent chronic neutrophilia during mycobacterial infections.

Authors:  R Appelberg; M T Silva
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

6.  Effects of granulocyte-macrophage colony-stimulating factor on wound contraction.

Authors:  M Robson; A Kucukcelebi; S S Carp; P G Hayward; P S Hui; W T Cowan; F Ko; D M Cooper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

7.  The detection and initial characterization of colony-stimulating factors in synovial fluid.

Authors:  D J Williamson; C G Begley; M A Vadas; D Metcalf
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

8.  Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue.

Authors:  Mark A Wortinger; Joseph W Foley; Patrick Larocque; Derrick R Witcher; Michael Lahn; Joseph A Jakubowski; Andrew Glasebrook; Ho Yeong Song
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

Review 9.  Role of endothelium in chronic inflammation.

Authors:  M Ziff
Journal:  Springer Semin Immunopathol       Date:  1989

10.  Flotillins are involved in the polarization of primitive and mature hematopoietic cells.

Authors:  Lawrence Rajendran; Julia Beckmann; Astrid Magenau; Eva-Maria Boneberg; Katharina Gaus; Antonella Viola; Bernd Giebel; Harald Illges
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.